Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Don Duval: Driving Innovation and Commercialization in Life Sciences

770 views

Published on

This keynote presentation was given at the global Bio-Connect Conference at the World Trade Centre Morelos in Cuernavaca, Mexico on November 29, 2011. The presentation highlighted the MaRS Life Sciences / Healthcare portfolio, the EXCITE pre-market assessment initiative in the Ontario healthcare system, and the role that MaRS Innovation plays to expedite the commercial outcomes from the intellectual property out of Canada's leading research and academic institutions.

Published in: Business, Economy & Finance
  • Be the first to comment

  • Be the first to like this

Don Duval: Driving Innovation and Commercialization in Life Sciences

  1. 1. Building Canada’s next generation ofgrowth companiesDriving Commercial Outcomes fromInnovation and Technology - The MaRSDiscovery District Case StudyNovember 29th 2011
  2. 2. There are three objectives that I hope to achieve intoday’s presentation: 1.  Provide an overview of MaRS, our mandate, and the programs and services we offer 2.  Discuss the MaRS Life Sciences and Healthcare Practice, MaRS Innovation, and the MaRS EXCITE program 3.  Provide an opportunity to address any questions you may have 2
  3. 3. MaRS is a non-profit innovation centre connecting science,technology and social entrepreneurs with business skills,networks and capital MaRS helps to create successful global Mission businesses from Canada s science and technology Who we Early stage science and technology ventures Serve and innovative social purpose businesses Measure of Job and wealth creation for the economy Success 3
  4. 4. 5
  5. 5. DiscoveryDetails inNotes Part ofSlide
  6. 6. pg  8  
  7. 7. Phase I" Phase II"
  8. 8. Discovery District Financial District Creative & Arts District Gardiner Museum of Ceramic ArtRoyal Conservatory of Music Royal Ontario Museum Women’s College University of Toronto The MaRS Centre UHN Toronto General UHN Princess Margaret Hospital for Sick children Mount Sinai Ryerson Toronto Rehab University Art Gallery of Ontario TIFF & OCAD Four Seasons Centre Financial District Entertainment District 10
  9. 9. pg  11  
  10. 10. Improving Commercialization Building Next GenerationOutput from Academe Startups 12
  11. 11. MaRS Innovation 13
  12. 12. ¨  A professionally managed, business accelerator platform as a single point of entry for industry partners and investors¨  Funding of MaRS Innovation and distribution of revenues are based upon an agreed upon formula amongst all member institutions¨  Currently trending with approximately 300 disclosures per year, approximately 70% of which are life sciences, medical device, or healthcare IT sectors¨  Cash contributions from member institutions are based pro- rata on the annual research budget for each institution 14
  13. 13. 
 
 
 Business Advice 
 Education
 Access 
 and Mentorship" and Insight" to Capital" " 
 " Advisors" Entrepreneurship Education Angels" Volunteers" Market Research" Venture Capital" " Thought Leadership" Corporations" Government Programs" Foundations" " Networks, Talent, Customers and Partners"Programs for High Growth Ventures, Policy Initiatives, and Special Projects " 15
  14. 14. Life Sciences and | ICE | Cleantech | Social Healthcare Intellectual Property Strategic Partnerships Marketing & Sales Financing Due Diligence Strategy and Business Planning Market/Competitive Intelligence Human Resources and Talent ManagementProduct Development and Marketing Legal Corporate Governance Operations and Process Customer Relationship Management Financial Management, Accounting, Tax MaRS Advisors | Partners | Volunteers 16
  15. 15. ¨  Approximately 125 active ventures in the MaRS portfolio, working with an array of mentors and advisors¨  Provision of market intelligence, educational resources, and continuing to build strong connections to capital and market opportunities¨  Highly integrated and supportive of MaRS Innovation clients; pipeline of high quality deal flow Logoʼs from ArcticDX, Profound Medical, " Pg 17
  16. 16. Licensing & Industry Co-development " Start-ups" Single Commercialization Business Accelerator Storefront for Toronto’s for Ontario’s Emerging Academic Institutions Companies Member Institutions" Entrepreneurs from across Ontario and the country" 18
  17. 17. Memory at Work Currently there is limited crosstalk during the development process can mean greatly protracted timelines before new technologies are adopted or even a reluctance to adopt new technologies NEW TECHNOLOGIES" END USERS" 19 Pg 19
  18. 18. 
 NOW" 
 
 New Canadian " New Canadian and International"Medical Technologies" Medical Technologies" Unrealized improvements
 Pre-market feedback loop" 
 
 Demand " More relevant disconnect" " technologies" " "A novel approach that matches health technology innovation 
 with patient needs and health system priorities" " 20
  19. 19. Memory at Work Technology Market Sub-optimal Adoption Development" Approval" by Health Systems"CurrentEvaluationProcess" Pre-Market" Post-Market" Evaluation" Evaluation" (Risk-Based)" (Evidence-Based)" Technology Development with Market Optimal Adoption by Evaluation Improvements" Approval" Health Systems"EXCITE Pre- Incorporates technologyMarket improvements"Evaluation Reflects health careProcess" Pre-Market" priorities" Evaluation" " (Evidence-Based)" 21
  20. 20. Impact" Real Estate Services " Ecosystem Development"Office & Laboratory Facilities | MaRS Incubator " Strategic Partnerships | Stakeholder Support"MaRS Collaboration Centre l " IT/AV Services" Community Programs |" Awards & Recognition" MaRS Centre Development " Talent & Knowledge Management " Public Policy " Business Services" IP Development |" Market Intelligence |" Capital & Investment" MaRS Advisory |" Entrepreneurship Education" 22
  21. 21. Don Duval"Email: dduval@marsdd.com"Twitter: don_duval"Speakerfile: don.duval"

×